Egyptian hepatitis b study seeks clues on drug resistance
NCT ID NCT07274345
First seen Jan 05, 2026 · Last updated May 02, 2026 · Updated 19 times
Summary
This study will check how often chronic hepatitis B patients in Egypt develop resistance to antiviral drugs. Researchers will look at 2,000 patients to find out which factors—like age, liver health, or virus type—make resistance more likely. The goal is to help doctors choose better treatments and improve long-term care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B - ANTIVIRAL DRUG RESISTANCE - HEPATITIS B VIRUS (HBV) INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.